Delivery of MicroRNA-126 by Apoptotic Bodies Induces CXCL12-Dependent Vascular Protection

Apoptotic endothelial cells release microRNA-containing microvesicles to modulate the responses of neighboring cells and reduce atherosclerosis in mice. Sounding the Alarm In addition to its importance in development and homeostasis, apoptotic cell death is implicated in a number of diseases, including atherosclerosis. Apoptotic endothelial cells at atherosclerotic plaques release microvesicles known as apoptotic bodies into the circulation, and their abundance correlates with negative indicators of disease. Zernecke et al. showed that apoptotic bodies from endothelial cells contained microRNA-126 (miR-126). Neighboring vascular cells took up the microvesicles, which allowed miR-126 to reduce the abundance of an inhibitor of the signaling of the chemokine receptor CXCR4, resulting in the increased production of CXCL12, the ligand for CXCR4. CXCL12 mediated the recruitment to atherosclerotic plaques of progenitor cells from the bone marrow, which limited plaque size. Apoptotic bodies isolated from human patients with atherosclerosis reduced the size of plaques in different mouse models of atherosclerosis. Thus, dying endothelial cells send alarm signals in the form of packaged microRNA to neighboring cells to trigger a healing response that reduces atherosclerosis. Apoptosis is a pivotal process in embryogenesis and postnatal cell homeostasis and involves the shedding of membranous microvesicles termed apoptotic bodies. In response to tissue damage, the CXC chemokine CXCL12 and its receptor CXCR4 counteract apoptosis and recruit progenitor cells. Here, we show that endothelial cell–derived apoptotic bodies are generated during atherosclerosis and convey paracrine alarm signals to recipient vascular cells that trigger the production of CXCL12. CXCL12 production was mediated by microRNA-126 (miR-126), which was enriched in apoptotic bodies and repressed the function of regulator of G protein (heterotrimeric guanosine triphosphate–binding protein) signaling 16, an inhibitor of G protein–coupled receptor (GPCR) signaling. This enabled CXCR4, a GPCR, to trigger an autoregulatory feedback loop that increased the production of CXCL12. Administration of apoptotic bodies or miR-126 limited atherosclerosis, promoted the incorporation of Sca-1+ progenitor cells, and conferred features of plaque stability on different mouse models of atherosclerosis. This study highlights functions of microRNAs in health and disease that may extend to the recruitment of progenitor cells during other forms of tissue repair or homeostasis.

[1]  Stefanie Dimmeler,et al.  Role of microRNAs in vascular diseases, inflammation, and angiogenesis. , 2008, Cardiovascular research.

[2]  John McAnally,et al.  The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. , 2008, Developmental cell.

[3]  Ru-Fang Yeh,et al.  miR-126 regulates angiogenic signaling and vascular integrity. , 2008, Developmental cell.

[4]  Joshua T. Mendell,et al.  MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1 , 2008, Proceedings of the National Academy of Sciences.

[5]  F. Tacke,et al.  Protective Role of CXC Receptor 4/CXC Ligand 12 Unveils the Importance of Neutrophils in Atherosclerosis , 2008, Circulation research.

[6]  Regina M. Krohn,et al.  Y-Box Binding Protein-1 Controls CC Chemokine Ligand-5 (CCL5) Expression in Smooth Muscle Cells and Contributes to Neointima Formation in Atherosclerosis-Prone Mice , 2007, Circulation.

[7]  Luigi Biancone,et al.  Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. , 2007, Blood.

[8]  S. Rafii,et al.  The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. , 2007, Trends in immunology.

[9]  J. Lötvall,et al.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.

[10]  A. Zernecke,et al.  Perivascular Mast Cells Promote Atherogenesis and Induce Plaque Destabilization in Apolipoprotein E–Deficient Mice , 2007, Circulation.

[11]  J. Bernhagen,et al.  MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment , 2007, Nature Medicine.

[12]  Y. Castier,et al.  Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. , 2007, Journal of the American College of Cardiology.

[13]  B Yan,et al.  Regulation of mammalian horizontal gene transfer by apoptotic DNA fragmentation , 2006, British Journal of Cancer.

[14]  Christian Weber,et al.  Ccr5 But Not Ccr1 Deficiency Reduces Development of Diet-Induced Atherosclerosis in Mice , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[15]  R. Plasterk,et al.  The diverse functions of microRNAs in animal development and disease. , 2006, Developmental cell.

[16]  T. Littlewood,et al.  Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis , 2006, Nature Medicine.

[17]  A. Zernecke,et al.  CD73/Ecto-5′-Nucleotidase Protects Against Vascular Inflammation and Neointima Formation , 2006, Circulation.

[18]  A. Zernecke,et al.  SDF-1alpha-mediated tissue repair by stem cells: a promising tool in cardiovascular medicine? , 2006, Trends in cardiovascular medicine.

[19]  D. Hume,et al.  Apoptotic cell removal in development and tissue homeostasis. , 2006, Trends in immunology.

[20]  Nikos Werner,et al.  Circulating CD31+/Annexin V+ Apoptotic Microparticles Correlate With Coronary Endothelial Function in Patients With Coronary Artery Disease , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[21]  W. Vainchenker,et al.  RGS16 is a negative regulator of SDF-1-CXCR4 signaling in megakaryocytes. , 2005, Blood.

[22]  H. Broxmeyer,et al.  SDF‐1/CXCL12 Enhances Survival and Chemotaxis of Murine Embryonic Stem Cells and Production of Primitive and Definitive Hematopoietic Progenitor Cells , 2005, Stem cells.

[23]  A. Zernecke,et al.  SDF-1&agr;/CXCR4 Axis Is Instrumental in Neointimal Hyperplasia and Recruitment of Smooth Muscle Progenitor Cells , 2005, Circulation research.

[24]  F. Arenzana‐Seisdedos,et al.  Functional characterization of SDF-1 proximal promoter. , 2005, Journal of molecular biology.

[25]  C. Thompson,et al.  Death by design: apoptosis, necrosis and autophagy. , 2004, Current opinion in cell biology.

[26]  M. Hristov,et al.  Apoptotic bodies from endothelial cells enhance the number and initiate the differentiation of human endothelial progenitor cells in vitro. , 2004, Blood.

[27]  T. Welte,et al.  Life after corpse engulfment: phagocytosis of apoptotic cells leads to VEGF secretion and cell growth , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  Anton J. Enright,et al.  Human MicroRNA Targets , 2004, PLoS biology.

[29]  M. Bennett,et al.  Role of apoptosis in atherosclerosis and its therapeutic implications. , 2004, Clinical science.

[30]  V. Ambros The functions of animal microRNAs , 2004, Nature.

[31]  Geoffrey C Gurtner,et al.  Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 , 2004, Nature Medicine.

[32]  K. Ravichandran,et al.  Cues for apoptotic cell engulfment: eat-me, don't eat-me and come-get-me signals. , 2003, Trends in cell biology.

[33]  S. Baksh,et al.  Apoptotic Cells Induce Migration of Phagocytes via Caspase-3-Mediated Release of a Lipid Attraction Signal , 2003, Cell.

[34]  P. Libby Inflammation in atherosclerosis , 2002, Nature.

[35]  S. Frøland,et al.  Stromal Cell–Derived Factor-1&agr; in Unstable Angina: Potential Antiinflammatory and Matrix-Stabilizing Effects , 2002, Circulation.

[36]  Lars Holmgren,et al.  Horizontal transfer of oncogenes by uptake of apoptotic bodies , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Christopher K. Glass,et al.  Atherosclerosis The Road Ahead , 2001, Cell.

[38]  R. Taichman,et al.  Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function. , 2000, The Journal of clinical investigation.

[39]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[40]  Thomas D. Schmittgen,et al.  Real-time PCR quantification of precursor and mature microRNA. , 2008, Methods.

[41]  A. Tedgui,et al.  Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease. , 2006, Hypertension.

[42]  W. Vainchenker,et al.  RGS 16 is a negative regulator of SDF-1 – CXCR 4 signaling in megakaryocytes , 2005 .

[43]  I. Iakovidis,et al.  The road ahead. , 2004, Studies in health technology and informatics.